MAXALT RPD
Identification of Maxalt Rpd
| No description |
Google image searchProduct monograph
Active ingredient
rizatriptan (rizatriptan benzoate), 10 MG
DIN: 02240519
Dosage form(s): TABLET (ORALLY DISINTEGRATING)
Route(s) of administration: ORAL
Schedule: Prescription
Company: ORGANON CANADA INC.
Date: 06-MAR-2023
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
- N02CC — Selective serotonin (5HT1) agonists (ATC, ATC/DDD)
- N02CC04 — RIZATRIPTAN (ATC/DDD)
Reference brand drug: Maxalt
Pharmaceutical standard: MFR
